Proehl Gerald T - Nov 23, 2021 Form 4 Insider Report for Dermata Therapeutics, Inc. (DRMA)

Role
President, CEO and Chairman, Director, 10%+ Owner
Signature
/s/ Gerald T. Proehl
Stock symbol
DRMA
Transactions as of
Nov 23, 2021
Transactions value $
$48,000
Form type
4
Date filed
11/26/2021, 12:30 PM
Previous filing
Aug 17, 2021
Next filing
Jan 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DRMA Common Stock Purchase $48K +20K +50.62% $2.40 59.5K Nov 23, 2021 Direct
holding DRMA Common Stock 17.9K Nov 23, 2021 By Allison Taylor Proehl 2020 Irrevocable Trust F1
holding DRMA Common Stock 8.93K Nov 23, 2021 By Meghan Proehl Wilder 2020 Irrevocable Trust F1
holding DRMA Common Stock 35.8K Nov 23, 2021 By Sean Michael Proehl 2020 Irrevocable Trust Dated December 18, 2020 F1
holding DRMA Common Stock 2.91M Nov 23, 2021 By Proehl Investment Ventures LLC F1
holding DRMA Common Stock 153K Nov 23, 2021 By Proehl Family Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.